Newton Biocapital

Newton Biocapital is a venture capital firm established in Belgium in 2017, focusing on financing biotech and life science projects in Europe and Japan aimed at the prevention and treatment of chronic diseases. (newtonbiocapital.com ) The firm's mission is to mature innovation and support the growth of its portfolio companies to create value for patients, society, local ecosystems, and investors. (newtonbiocapital.com ) By leveraging innovation to develop solutions for chronic health conditions, Newton Biocapital helps create value for: Patients : Funding efforts for affordable healthcare solutions that address unmet medical needs. Society : Easing pressure on insurance and reimbursement systems burdened by chronic health conditions. Local ecosystems : Attracting investors and promoting company growth, leading to improved sector employment. Investors : Supporting portfolio company value creation and setting the scene for successful exits. Newton Biocapital invests in both Europe and Japan, assisting early-stage companies in unlocking their full potential by opening doors to global pharmaceutical and investment networks. (newtonbiocapital.com ) The firm's investment approach is based on three core pillars: Thorough selection : Identifying innovative solutions to chronic health conditions where the burden to both patients and reimbursement systems is high. Hands-on support : Actively involving with portfolio companies as board members, preferably as lead investor, to help build their strategy and choose programs most likely to reach proof of concept and demonstrate therapeutic efficacy. Optimal exits : Supporting company growth and guiding companies towards the best possible exit strategies through local and international connections. Newton Biocapital has launched two funds: Newton Biocapital I : Initiated in 2017 with a fund size of EUR 114 million, building a diverse and balanced portfolio of 14 companies, including 10 European and 4 Japanese companies. (newtonbiocapital.com ) Newton Biocapital II : Initiated at the end of 2021 with a fund size of EUR 53 million, currently building a diverse and balanced portfolio with 3 European and 1 Japanese company. (newtonbiocapital.com ) The leadership team consists of specialists with long-standing management and investor experience who coach bio-entrepreneurs through the development stages of their projects. (newtonbiocapital.com ) Newton Biocapital is committed to sustainable development and responsible investment, integrating Environmental, Social, and Corporate Governance (ESG) principles into its investment decisions. (newtonbiocapital.com ) The firm has offices in Brussels, Belgium, and Tokyo, Japan, reflecting its strong ties to the life sciences ecosystems of both regions. (newtonbiocapital.com )